https://clinicum.pediatrics.wisc.edu/2020/07/29/allogeneic-hematopoietic-stem-cell-transplant-for-patients-with-primary-immune-deficiencies/2020-08-04T17:46:47+00:00https://clinicum.pediatrics.wisc.edu/2020/07/29/hematopoietic-stem-cell-transplant-for-patients-with-primary-immune-deficiencies/2020-08-04T17:15:54+00:00https://clinicum.pediatrics.wisc.edu/2020/08/04/allogeneic-hematopoietic-stem-cell-transplant-for-patients-with-primary-immune-deficiencies-5/2020-08-04T17:18:44+00:00https://clinicum.pediatrics.wisc.edu/2020/08/04/mt2013-31-allo-hct-for-metabolic-disorders-and-severe-osteopetrosis/2020-08-04T17:37:55+00:00https://clinicum.pediatrics.wisc.edu/2020/08/18/treatment-of-relapsed-or-refractory-neuroblastoma-with-expanded-haploidentical-nk-cells-and-hu14-18-il2/2020-08-19T17:11:22+00:00https://clinicum.pediatrics.wisc.edu/2020/08/19/phase-2-stir-trial-haploidentical-transplant-and-donor-natural-killer-cells-for-solid-tumors-stir/2020-08-25T16:12:50+00:00https://clinicum.pediatrics.wisc.edu/2020/08/19/myeloablative-consolidation-therapy-and-tandem-autologous-stem-cell-rescue-in-patients-with-high-risk-neuroblastoma/2020-08-19T17:10:17+00:00https://clinicum.pediatrics.wisc.edu/2020/08/19/mibg-for-refractory-neuroblastoma-and-pheochromocytoma/2020-08-19T17:36:26+00:00https://clinicum.pediatrics.wisc.edu/2020/08/20/safety-tolerability-efficacy-and-pharmacokinetics-of-copanlisib-in-pediatric-patients/2020-08-20T02:24:11+00:00https://clinicum.pediatrics.wisc.edu/2020/08/20/dosimetry-guided-peptide-receptor-radiotherapy-prrt-with-90y-dota-tyr3-octreotide-90y-dotatoc/2020-08-25T17:01:10+00:00https://clinicum.pediatrics.wisc.edu/2020/08/20/safety-of-68ga-dota-tyr3-octreotide-pet-in-diagnosis-of-solid-tumors-ga-68/2020-08-25T17:02:01+00:00https://clinicum.pediatrics.wisc.edu/2020/08/20/theranostics-68gadotatoc-and-90ydotatoc-prrt/2020-08-25T17:02:39+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/a-study-of-therapeutic-iobenguane-131-i-for-relapsed-high-risk-neuroblastoma-subjects-optimum/2020-08-24T17:34:50+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/immunotherapy-of-relapsed-refractory-neuroblastoma-with-expanded-nk-cells/2020-09-01T14:53:16+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/sorafenib-and-cyclophosphamide-topotecan-in-patients-with-relapsed-and-refractory-neuroblastoma-n2013-02/2020-09-01T14:53:58+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/lenalidomide-and-dinutuximab-with-or-without-isotretinoin-in-treating-younger-patients-with-refractory-or-recurrent-neuroblastoma/2020-09-01T14:54:36+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/mibg-with-dinutuximab/2020-09-01T14:55:18+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/n2012-01-phase-1-study-of-difluoromethylornithine-dfmo-and-celecoxib-with-cyclophosphamide-topotecan-dfmo/2020-09-01T14:56:15+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/131i-mibg-alone-vs-131i-mibg-with-vincristine-and-irinotecan-vs-131i-mibg-with-vorinistat-n2011-01/2020-09-01T14:57:06+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/naxitamab-for-high-risk-neuroblastoma-patients-with-primary-refractory-disease-or-incomplete-response-to-salvage-treatment-in-bone-and-or-bone-marrow/2020-09-01T14:57:44+00:00https://clinicum.pediatrics.wisc.edu/2020/08/24/nant-2015-02-a-phase-1-study-of-lorlatinib-pf-06463922/2020-09-01T14:58:18+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/dose-escalation-study-of-clr-131-in-children-and-adolescents-with-relapsed-or-refractory-malignant-tumors-including-but-not-limited-to-neuroblastoma-rhabdomyosarcoma-ewings-sarcoma-and-osteosarcoma-3/2021-01-15T02:40:56+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/abemaciclib-for-treatment-of-advanced-bone-and-soft-tissue-sarcoma-identified-as-having-cdk-pathway-alteration/2020-08-25T13:53:41+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/alpha-beta-cd19-depleted-haploidentical-transplantation-zometa-for-pediatric-hematologic-malignancies-and-solid-tumors-4/2021-01-15T15:12:28+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/auto-transplant-for-high-risk-or-relapsed-solid-or-cns-tumors/2020-08-25T16:58:13+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/modified-measles-virus-mv-nis-for-children-and-young-adults-with-recurrent-medulloblastoma-or-recurrent-atrt/2020-08-25T17:05:16+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/metronomic-and-targeted-anti-angiogenesis-therapy-for-children-with-recurrent-progressive-medulloblastoma-memmat/2020-08-25T17:07:48+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/safety-and-efficacy-study-in-recurrent-grade-iv-glioma/2020-08-25T17:41:46+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/clinical-benefit-of-using-molecular-profiling-to-determine-an-individualized-treatment-plan-for-patients-with-high-grade-glioma-pnoc008/2020-08-25T17:48:03+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/selinexor-in-treating-younger-patients-with-recurrent-or-refractory-solid-tumors-or-high-grade-gliomas/2020-08-25T17:50:42+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/cb-839-with-radiation-therapy-and-temozolomide-in-treating-participants-with-idh-mutated-diffuse-astrocytoma-or-anaplastic-astrocytoma/2020-08-25T17:53:15+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/trial-of-heat-shock-protein-peptide-complex-96-hsppc-96-vaccine/2020-08-25T17:57:29+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/a-phase-i-study-of-adv-tk-prodrug-therapy-in-combination-with-radiation-therapy-for-pediatric-brain-tumors/2020-08-25T18:00:10+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/a-study-of-ribociclib-and-everolimus-following-radiation-therapy-in-children-with-newly-diagnosed-non-biopsied-diffuse-pontine-gliomas-dipg-and-rb-biopsied-dipg-and-high-grade-gliomas-hgg/2020-08-25T18:16:55+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/myeloablative-conditioning-prophylactic-defibrotide-and-haplo-allosct-for-patients-with-sickle-cell-disease-nymc-571/2020-08-25T19:04:13+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/haplo-t-cell-depleted-transplantation-in-high-risk-sickle-cell-disease-haploscd/2020-08-25T19:18:36+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/a-study-evaluating-gene-therapy-with-bb305-lentiviral-vector-in-sickle-cell-disease/2020-08-25T19:23:02+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/haploidentical-allogeneic-hematopoietic-stem-cell-transplantation-haplohct-following-reduced-intensity-conditioning-ric-for-selected-high-risk-non-malignant-diseases/2020-08-25T19:28:42+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/hematopoietic-stem-cell-transplant-for-high-risk-hemoglobinopathies/2020-08-25T19:43:20+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/haploidentical-hematopoietic-stem-cell-transplantation-hsct-for-patients-with-severe-sickle-cell-disease/2020-09-01T15:00:47+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/ph-i-ii-study-of-allogeneic-sct-for-clinically-aggressive-sickle-cell-disease-scd/2020-09-01T15:02:14+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/study-of-hla-haploidentical-stem-cell-transplantation-to-treat-clinically-aggressive-sickle-cell-disease/2020-09-01T15:02:47+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/sickle-cell-pro-inflammatory-response-to-interval-training-study-sprints/2020-09-01T15:03:38+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/dissemination-and-implementation-of-stroke-prevention-looking-at-the-care-environment-displace/2020-09-01T15:04:22+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/a-safety-and-efficacy-study-evaluating-ctx001-in-subjects-with-severe-sickle-cell-disease/2020-09-01T15:05:15+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/integration-of-mhealth-into-the-care-of-patients-with-sickle-cell-disease-to-increase-hydroxyurea-utilization/2020-09-01T16:27:58+00:00https://clinicum.pediatrics.wisc.edu/2020/08/25/a-sad-mad-to-assess-the-safety-pharmacokinetics-and-pharmacodynamics-of-ft-4202-in-healthy-volunteers-and-sickle-cell-disease-patients/2020-09-01T16:29:04+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/minimizing-toxicity-in-hla-identical-related-donor-transplantation-for-children-with-sickle-cell-disease-sun/2020-09-01T16:31:23+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/abatacept-for-gvhd-prophylaxis-after-hematopoietic-stem-cell-transplantation-for-pediatric-sickle-cell-disease/2020-09-01T16:33:41+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/shared-decision-making-for-hydroxyurea-engage-hu/2020-09-01T16:35:17+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/acute-gvhd-suppression-using-costimulation-blockade-to-expand-non-malignant-transplant-ascent/2020-09-01T17:36:57+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/myeloablative-conditioning-prophylactic-defibrotide-and-haplo-allosct-for-patients-with-sickle-cell-disease-nymc-571-2/2020-09-01T16:41:46+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/haploidentical-allogeneic-hematopoietic-stem-cell-transplantation-haplohct-following-reduced-intensity-conditioning-ric-for-selected-high-risk-non-malignant-diseases-2/2020-09-01T17:22:21+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/a-study-evaluating-the-efficacy-and-safety-of-the-lentiglobin-bb305-drug-product-in-subjects-with-transfusion-dependent-%ce%b2-thalassemia/2020-09-01T17:38:22+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/hematopoietic-stem-cell-transplant-for-dyskeratosis-congenita-or-severe-aplastic-anemia/2020-09-01T17:26:22+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/tbi-dose-de-escalation-for-fanconi-anemia/2020-09-01T17:29:15+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/cytoxan-fludara-and-antithymocyte-globulin-conditioning-followed-by-stem-cell-transplant-in-treating-fanconi-anemia/2020-09-01T17:31:40+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/hematopoietic-stem-cell-transplantation-in-high-risk-patients-with-fanconi-anemia/2020-09-01T17:33:42+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/t-cell-receptor-%ce%b1-%ce%b2-tcd-hct-in-patients-with-fanconi-anemia/2020-09-01T17:36:08+00:00https://clinicum.pediatrics.wisc.edu/2020/09/01/radiation-and-alkylator-free-bone-marrow-transplantation-regimen-for-patients-with-dyskeratosis-congenita/2020-10-09T20:45:54+00:00https://clinicum.pediatrics.wisc.edu/2020/10/15/treatment-of-cytomegalovirus-cmv-infections-with-viral-specific-t-cells/2020-10-15T17:39:32+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/phase-ii-open-label-trial-to-determine-safety-efficacy-of-tisagenlecleucel-in-pediatric-non-hodgkin-lymphoma-patients-bianca/2021-01-15T15:18:18+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/auto-stem-cell-transplant-for-lymphoma-patients/2021-01-15T15:22:04+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/umbilical-cord-blood-transplantation-using-a-myeloablative-preparative-regimen-for-hematological-diseases/2021-01-15T15:47:16+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/allo-hsct-using-ric-for-hematological-diseases/2021-01-15T15:49:58+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/myeloablative-allo-hsct-with-related-or-unrelated-donor-for-heme-disorders/2021-01-15T16:18:47+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/reduced-intensity-ric-conditioning-and-transplantation-of-hla-haploidentical-related-hematopoietic/2021-01-15T16:22:03+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/ucb-transplant-for-hematological-diseases-using-a-non-myeloablative-prep/2021-01-15T16:26:17+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/mt2017-45-car-t-cell-therapy-for-heme-malignancies/2021-01-15T16:44:34+00:00https://clinicum.pediatrics.wisc.edu/2021/01/15/trial-evaluating-mgta-456-in-patients-with-high-risk-malignancy/2021-01-15T16:47:44+00:00